Who Makes Belzutifan: Welireg and Merck/ MSD Explained
Belzutifan is the first-in-class oral HIF-2αinhibitor to reach market.The originator brand is Welireg,40mg tablets,dosed 120mg once daily,with or without food.
Development lineage:The molecule(PT2977)came out of Peloton Therapeutics,building on the HIF-2αallosteric pocket identified at UT Southwestern.Merck acquired Peloton in 2019 and carried the program forward.On August 13,2021,the FDA approved Welireg under priority review for adults with von Hippel-Lindau disease–associated RCC,CNS hemangioblastoma,or pNET not requiring immediate surgery—the first HIF-2αinhibitor ever approved.
Corporate identity:
Group level:Merck&Co.,Inc.,operating as MSDoutside the US and Canada.
Label/MAH level:Merck Sharp&Dohme LLC(US)or Merck Sharp&Dohme(UK)Limitedand other local MSD entities.
So“Merck/MSD/Merck Sharp&Dohme”all map to the same originator system,but marketing-authorization holders,packagers,and supply sites differ by country—do not collapse them into one factory.
Originator vs.other brands:
The originator is the product that first completed development and obtained approval—that is Welireg.Some overseas markets now list other belzutifan brands(e.g.,LUCIBELZU by Luoxus in Laos).To tell them apart,check beyond“belzutifan 40mg”:
Brand nameon the carton—Welireg indicates originator;
Manufacturer/MAH—is it an MSD/Merck Sharp&Dohme entity;
Local registration number,approval status,batch number—verifiable in the destination regulator’s database;
For non-originator versions,whether the local authority requires bioequivalence data,GMP certification,and traceability.
Prices may differ across markets and brands,but price is not a quality proxy.
Safety note:Belzutifan can cause severe hypoxia—monitor SpO₂by pulse oximetry before and frequently during early treatment;grade 2 hypoxia warrants oxygen and reassessment,grade 3 holds therapy and considers dose reduction,grade 4 is permanent discontinuation.Anemia,fatigue,nausea,and embryo-fetal toxicity also apply;contraception is required for people of reproductive potential.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)